lentiviral cas9 expression construct lenticas9 blast (Addgene inc)
Structured Review
![Fig. 2 Oncogene exposure transforms induced hepatocytes but not control fibroblasts. A Phase contrast microscope images showing the phenotype and morphology of the cells in the course of conversion of fibroblasts to iHeps at different times points after transduction with a cocktail of three TFs HNF1A, HNF4A and FOXA3 [36]. B Generation of highly proliferative iHep cells by transducing iHeps with two pools of liver cancer-specific oncogenic drivers, a list of xenograft experiments in nude mice that were used to test the tumorigenicity of different conditions, and mutation rates of the oncogenic drivers as reported in the COSMIC database for HCC and MYC amplification as reported in [43]. CMT pool contains three oncogenes CTNNB1T41A, MYC, and TERT, and CMT + sgTP53 pool contains the same oncogenes along with constructs for TP53 inactivation by <t>CRISPR-Cas9.</t> Phase contrast microscope images showing the phenotype and morphology of the cells. Oncogenes are co-transduced with fluorescent reporter mCherry for the detection of transduced cells. Oncogene transduction to fibroblasts fails to transform the cells, passaging of oncogene-expressing fibroblasts results in cellular senescence as demonstrated by β-galactosidase staining and loss of mCherry-positive oncogene-expressing cells from the fibroblast population. iHeps maintained in defined culture medium become senescent around week four of transdifferentiation although they can survive in culture for several weeks after that if not passaged. Passaging of iHeps without oncogenes results in apoptosis after few passages. Scale bar 1000 μm unless otherwise specified.](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_2118/pm34302118/pm34302118__page3_image1.jpg)
Lentiviral Cas9 Expression Construct Lenticas9 Blast, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1687 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas9+expression+construct/lentiCas9-Blast+(Plasmid+%2352962)/pm34302118-213-5-41
Average 96 stars, based on 1687 article reviews
Images
1) Product Images from "Human cell transformation by combined lineage conversion and oncogene expression."
Article Title: Human cell transformation by combined lineage conversion and oncogene expression.
Journal: Oncogene
doi: 10.1038/s41388-021-01940-0
Figure Legend Snippet: Fig. 2 Oncogene exposure transforms induced hepatocytes but not control fibroblasts. A Phase contrast microscope images showing the phenotype and morphology of the cells in the course of conversion of fibroblasts to iHeps at different times points after transduction with a cocktail of three TFs HNF1A, HNF4A and FOXA3 [36]. B Generation of highly proliferative iHep cells by transducing iHeps with two pools of liver cancer-specific oncogenic drivers, a list of xenograft experiments in nude mice that were used to test the tumorigenicity of different conditions, and mutation rates of the oncogenic drivers as reported in the COSMIC database for HCC and MYC amplification as reported in [43]. CMT pool contains three oncogenes CTNNB1T41A, MYC, and TERT, and CMT + sgTP53 pool contains the same oncogenes along with constructs for TP53 inactivation by CRISPR-Cas9. Phase contrast microscope images showing the phenotype and morphology of the cells. Oncogenes are co-transduced with fluorescent reporter mCherry for the detection of transduced cells. Oncogene transduction to fibroblasts fails to transform the cells, passaging of oncogene-expressing fibroblasts results in cellular senescence as demonstrated by β-galactosidase staining and loss of mCherry-positive oncogene-expressing cells from the fibroblast population. iHeps maintained in defined culture medium become senescent around week four of transdifferentiation although they can survive in culture for several weeks after that if not passaged. Passaging of iHeps without oncogenes results in apoptosis after few passages. Scale bar 1000 μm unless otherwise specified.
Techniques Used: Control, Microscopy, Transduction, Mutagenesis, Construct, CRISPR, Passaging, Expressing, Staining
Related Articles
Recombinant:Article Title: SPARCS enables scalable recovery of complex image-based phenotypes for genetic screening. Article Snippet: Human female U2OS and HeLa cells were cultured in DMEM (Thermo Fisher Scientific #41965062) supplemented with 10 % fetal calf serum (FCS) (gibco #10270-106), penicillin/streptomycin (Thermo Fisher Scientific #15-140-122) and 1 mM sodium pyruvate (Thermo .. REAGENT or RESOURCE SOURCE IDENTIFIER GPR89B_crRNA_2 rUrCrArCrUrCrCrArArUrCrArCrArCrCrArAr CrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU Integrated DNA Technologies n/a Recombinant DNA Genome-wide human Brunello CRISPR library (LentiGUIDE-Puro) Doench et al.57 Addgene-73178 Genome-wide human Brunello CRISPR library (LentiCRISPRv2) Doench et al.57 Addgene-73179 pFUGW-mCherry-hsLC3 This study, Jahreiss et al.103 Addgene-40827 pFUGW-LckLip-mNeon This study, Chertkova et al.104 Addgene-98821 pLenti6-MGAT-SEP-mRuby3 This study, Liu et al.75 Addgene-200937 pLenti6-GALT-SEP-mRuby3 This study, Liu et al.75 Addgene-200938 pBlast_hsGPR89B_FLAG This study n/a pFUGW_hsSTING1_mNeon This study n/a Lenti-Cas9-Blast Sanjana et Genome Wide:Article Title: SPARCS enables scalable recovery of complex image-based phenotypes for genetic screening. Article Snippet: Human female U2OS and HeLa cells were cultured in DMEM (Thermo Fisher Scientific #41965062) supplemented with 10 % fetal calf serum (FCS) (gibco #10270-106), penicillin/streptomycin (Thermo Fisher Scientific #15-140-122) and 1 mM sodium pyruvate (Thermo .. REAGENT or RESOURCE SOURCE IDENTIFIER GPR89B_crRNA_2 rUrCrArCrUrCrCrArArUrCrArCrArCrCrArAr CrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU Integrated DNA Technologies n/a Recombinant DNA Genome-wide human Brunello CRISPR library (LentiGUIDE-Puro) Doench et al.57 Addgene-73178 Genome-wide human Brunello CRISPR library (LentiCRISPRv2) Doench et al.57 Addgene-73179 pFUGW-mCherry-hsLC3 This study, Jahreiss et al.103 Addgene-40827 pFUGW-LckLip-mNeon This study, Chertkova et al.104 Addgene-98821 pLenti6-MGAT-SEP-mRuby3 This study, Liu et al.75 Addgene-200937 pLenti6-GALT-SEP-mRuby3 This study, Liu et al.75 Addgene-200938 pBlast_hsGPR89B_FLAG This study n/a pFUGW_hsSTING1_mNeon This study n/a Lenti-Cas9-Blast Sanjana et CRISPR:Article Title: SPARCS enables scalable recovery of complex image-based phenotypes for genetic screening. Article Snippet: Human female U2OS and HeLa cells were cultured in DMEM (Thermo Fisher Scientific #41965062) supplemented with 10 % fetal calf serum (FCS) (gibco #10270-106), penicillin/streptomycin (Thermo Fisher Scientific #15-140-122) and 1 mM sodium pyruvate (Thermo .. REAGENT or RESOURCE SOURCE IDENTIFIER GPR89B_crRNA_2 rUrCrArCrUrCrCrArArUrCrArCrArCrCrArAr CrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU Integrated DNA Technologies n/a Recombinant DNA Genome-wide human Brunello CRISPR library (LentiGUIDE-Puro) Doench et al.57 Addgene-73178 Genome-wide human Brunello CRISPR library (LentiCRISPRv2) Doench et al.57 Addgene-73179 pFUGW-mCherry-hsLC3 This study, Jahreiss et al.103 Addgene-40827 pFUGW-LckLip-mNeon This study, Chertkova et al.104 Addgene-98821 pLenti6-MGAT-SEP-mRuby3 This study, Liu et al.75 Addgene-200937 pLenti6-GALT-SEP-mRuby3 This study, Liu et al.75 Addgene-200938 pBlast_hsGPR89B_FLAG This study n/a pFUGW_hsSTING1_mNeon This study n/a Lenti-Cas9-Blast Sanjana et Article Title: FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma. Article Snippet: .. Gene expression knockout with CRISPR/Cas9 HTLV-1 infected (MT-4) and ATL (ATL-55T) cell lines were transduced to stably express Cas9 using the Data-independent acquisition:Article Title: SPARCS enables scalable recovery of complex image-based phenotypes for genetic screening. Article Snippet: Human female U2OS and HeLa cells were cultured in DMEM (Thermo Fisher Scientific #41965062) supplemented with 10 % fetal calf serum (FCS) (gibco #10270-106), penicillin/streptomycin (Thermo Fisher Scientific #15-140-122) and 1 mM sodium pyruvate (Thermo .. REAGENT or RESOURCE SOURCE IDENTIFIER GPR89B_crRNA_2 rUrCrArCrUrCrCrArArUrCrArCrArCrCrArAr CrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU Integrated DNA Technologies n/a Recombinant DNA Genome-wide human Brunello CRISPR library (LentiGUIDE-Puro) Doench et al.57 Addgene-73178 Genome-wide human Brunello CRISPR library (LentiCRISPRv2) Doench et al.57 Addgene-73179 pFUGW-mCherry-hsLC3 This study, Jahreiss et al.103 Addgene-40827 pFUGW-LckLip-mNeon This study, Chertkova et al.104 Addgene-98821 pLenti6-MGAT-SEP-mRuby3 This study, Liu et al.75 Addgene-200937 pLenti6-GALT-SEP-mRuby3 This study, Liu et al.75 Addgene-200938 pBlast_hsGPR89B_FLAG This study n/a pFUGW_hsSTING1_mNeon This study n/a Lenti-Cas9-Blast Sanjana et Laser Capture Microdissection:Article Title: SPARCS enables scalable recovery of complex image-based phenotypes for genetic screening. Article Snippet: Human female U2OS and HeLa cells were cultured in DMEM (Thermo Fisher Scientific #41965062) supplemented with 10 % fetal calf serum (FCS) (gibco #10270-106), penicillin/streptomycin (Thermo Fisher Scientific #15-140-122) and 1 mM sodium pyruvate (Thermo .. REAGENT or RESOURCE SOURCE IDENTIFIER GPR89B_crRNA_2 rUrCrArCrUrCrCrArArUrCrArCrArCrCrArAr CrCrGrUrUrUrUrArGrArGrCrUrArUrGrCrU Integrated DNA Technologies n/a Recombinant DNA Genome-wide human Brunello CRISPR library (LentiGUIDE-Puro) Doench et al.57 Addgene-73178 Genome-wide human Brunello CRISPR library (LentiCRISPRv2) Doench et al.57 Addgene-73179 pFUGW-mCherry-hsLC3 This study, Jahreiss et al.103 Addgene-40827 pFUGW-LckLip-mNeon This study, Chertkova et al.104 Addgene-98821 pLenti6-MGAT-SEP-mRuby3 This study, Liu et al.75 Addgene-200937 pLenti6-GALT-SEP-mRuby3 This study, Liu et al.75 Addgene-200938 pBlast_hsGPR89B_FLAG This study n/a pFUGW_hsSTING1_mNeon This study n/a Lenti-Cas9-Blast Sanjana et Knock-Out:Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers Article Snippet: .. RT112/84 wild-type and ERCC4 -knockout isogenic cell lines were first transduced with Article Title: FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma. Article Snippet: .. Gene expression knockout with CRISPR/Cas9 HTLV-1 infected (MT-4) and ATL (ATL-55T) cell lines were transduced to stably express Cas9 using the Transduction:Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers Article Snippet: .. RT112/84 wild-type and ERCC4 -knockout isogenic cell lines were first transduced with Stable Transfection:Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers Article Snippet: .. RT112/84 wild-type and ERCC4 -knockout isogenic cell lines were first transduced with Article Title: FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma. Article Snippet: .. Gene expression knockout with CRISPR/Cas9 HTLV-1 infected (MT-4) and ATL (ATL-55T) cell lines were transduced to stably express Cas9 using the Expressing:Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers Article Snippet: .. RT112/84 wild-type and ERCC4 -knockout isogenic cell lines were first transduced with Article Title: A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer Article Snippet: The gRNAs were cloned into the LRG2.1 sgRNA vector (Addgene #108098) using the CRISPR cloning strategy described by Tarumoto et al. [ ]. .. PC3 cells were transfected with the AXL -targeting LRG2.1 plasmids together with a Gene Expression:Article Title: FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma. Article Snippet: .. Gene expression knockout with CRISPR/Cas9 HTLV-1 infected (MT-4) and ATL (ATL-55T) cell lines were transduced to stably express Cas9 using the Infection:Article Title: FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma. Article Snippet: .. Gene expression knockout with CRISPR/Cas9 HTLV-1 infected (MT-4) and ATL (ATL-55T) cell lines were transduced to stably express Cas9 using the Transfection:Article Title: SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome Article Snippet: Guide RNA (gRNAs) were cloned into lentiGuide-Puro (Addgene #52963) and pFgH1UTPuro (Addgene #70183 with the GFP reporter replaced by puromycin resistance). .. HEK293T cells at 80% confluency were transfected via calcium phosphate-mediated transfection with the psPAX packaging vector, the VSVg envelope vector, and a plasmid containing either a SMCHD1 gRNA or Article Title: A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer Article Snippet: The gRNAs were cloned into the LRG2.1 sgRNA vector (Addgene #108098) using the CRISPR cloning strategy described by Tarumoto et al. [ ]. .. PC3 cells were transfected with the AXL -targeting LRG2.1 plasmids together with a Article Title: Development of Next-Generation ALDH1B1 Inhibitors with Enhanced Pharmacological and Functional Properties. Article Snippet: .. PDAC 24T cells (320,000 cells) were suspended in 400 μL transfection media (WENR media supplemented with 20 μM Y27632, 20 μM CHIR 99021, and 8 μg/mL polybrene) and treated with 325 μL WENR media and 75 μL lentiCas9-blast (Addgene #52962) Plasmid Preparation:Article Title: SMCHD1 is a target for gene activation therapy to treat Prader-Willi syndrome Article Snippet: Guide RNA (gRNAs) were cloned into lentiGuide-Puro (Addgene #52963) and pFgH1UTPuro (Addgene #70183 with the GFP reporter replaced by puromycin resistance). .. HEK293T cells at 80% confluency were transfected via calcium phosphate-mediated transfection with the psPAX packaging vector, the VSVg envelope vector, and a plasmid containing either a SMCHD1 gRNA or Article Title: A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer Article Snippet: The gRNAs were cloned into the LRG2.1 sgRNA vector (Addgene #108098) using the CRISPR cloning strategy described by Tarumoto et al. [ ]. .. PC3 cells were transfected with the AXL -targeting LRG2.1 plasmids together with a other:Article Title: Functional identification of non-coding regulatory regions that drive breast and skin carcinogenesis. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Pooled sgRNA library – human nonFMRE control library (3,539 sgRNAs) GenScript (pooled chip synthesis) N/A Pooled NTC library (1,778 non-targeting control sgRNAs) Sanjana et al.81; Al-Zahrani et al.24 N/A Pooled dgRNA library – human FMRE CRISPR-A library GenScript (pooled chip synthesis) N/A Pooled sgRNA library – mouse mFMRE library (694 sgRNAs) GenScript (pooled chip synthesis) N/A Pooled sgRNA library – mouse nonFMRE control library (1,934 sgRNAs) GenScript (pooled chip synthesis) N/A Pooled NTC library for mouse (420 nontargeting control sgRNAs) This paper N/A Individual validation gRNAs (ZFP36L2, VMP1/miR21, TBC1D12, POLR3E, LNPEP, PTEN, TP53, AAVS1, TIGRE, UROD, B2M) This paper N/A RT-qPCR primers (PPIB, ZFP36L2, B2M, VMP1); sequences in Method Details This paper N/A Recombinant DNA pLKO-Cre lentiviral vector Loganathan et al.48; Loganathan et al.50 |
![( A ) Plot of the candidate genes from <t>CRISPR-Cas9</t> knockout (KO) screen in LNCaP cells treated with 450 nM ipatasertib on day 18. ( B ) Top genes identified from the CRISPR-Cas9 KO screen on day 18 (ipatasertib-treated LNCaP cells compared to DMSO-treated cells). ( C ) TSC2-KO LNCaP cells were subjected to a 4-hour treatment with either DMSO or 500 nM ipatasertib. Expression levels of downstream targets in the PI3K pathway were evaluated using Western Blot analysis. ( D and E ) Outcomes of a competition assay involving four candidate genes in LNCaP cells. Cells were transduced with lentivirus carrying sgNT-GFP or sgRNA-GFP targeting the candidate genes, each with two specific sgRNAs. Following transduction, cells were treated with either DMSO or 500 nM ipatasertib. The ratio of GFP + cells was normalized to the DMSO treatment group. The data represent the results of three independent experiments ( n = 3). ( F ) LNCaP, CWR22Pc-EP-sgPTEN, and PCa12, each stably expressing sgNT or sgNPRL3, were subjected to treatment with either ipatasertib (500 nM) or DMSO. Cell viability on day 7 was assessed. ( G ) WT, TSC2-KO, or NPRL3-KO LNCaP cells were exposed to 6 hours of starvation and a 4-hour treatment with either DMSO or 500 nM ipatasertib. Following this, cells were stimulated with or without amino acids for 10 min. The expression levels of downstream targets in the PI3K pathway were evaluated using Western Blot analysis {* P < 0.05, ** P < 0.01, and **** P < 0.0001; [(D) to (F)] Welch’s t test; error bar represents ±SEM}.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4928/pmc11804928/pmc11804928__sciadv.adq3802-f3.jpg)

